Statement of Changes in Beneficial Ownership (4)
June 26 2020 - 1:26PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
SAMUELSON JAMES F |
2. Issuer Name and Ticker or Trading Symbol
CANNAPHARMARX, INC.
[
CPMD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
2 PARK PLAZA, SUITE 400 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/20/2018 |
(Street)
IRVINE, CA 92614
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Convertible Preferred Stock | $0.00 | 4/20/2018 | | J (2) | | 10000 | | 4/20/2018 | (1) | Common Stock | 12500000 | $1.00 | 31000000 | D | |
Explanation of Responses: |
(1) | The conversion righes of the Series A Convertible Preferred Stock do not expire and can be converted at any time. |
(2) | The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
SAMUELSON JAMES F 2 PARK PLAZA, SUITE 400 IRVINE, CA 92614 | X | X |
|
|
Signatures
|
/s/ James Samuelson | | 6/26/2020 |
**Signature of Reporting Person | Date |
Cannapharmarx (CE) (USOTC:CPMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cannapharmarx (CE) (USOTC:CPMD)
Historical Stock Chart
From Apr 2023 to Apr 2024